Jeopardy! host Alex Trebek has stage 4 pancreatic cancer

  • 📰 thenewpaper
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Alex Trebek, the beloved host of US game show Jeopardy!, announced on Wednesday that he was diagnosed stage 4 pancreatic cancer. The 78-year-old Canadian said in a video shared on the show's Twitter account that he planned to 'beat the low survival rates for this illness'...

Alex Trebek, the beloved host of US game show Jeopardy!, announced on Wednesday that he was diagnosed stage 4 pancreatic cancer.

The 78-year-old Canadian said in a video shared on the show's Twitter account that he planned to"beat the low survival rates for this illness" and keep working on NBC's long-running syndicated TV show. He added:"Truth be told, I have to - because under the terms of my contract, I have to host Jeopardy! for three more years!""So help me. Keep the faith, and we'll win. We'll get it done," he said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 7. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Jeopardy! host Alex Trebek diagnosed with stage 4 pancreatic cancer
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Jeopardy! host Alex Trebek diagnosed with stage 4 pancreatic cancer
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

ImmunoGen's ovarian cancer drug fails in late-stage studyREUTERS: U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Alnylam's gene-silencing drug meets main goal in late-stage studyREUTERS: Alnylam Pharmaceuticals Inc said on Wednesday its gene-silencing drug for treating a rare, painful disease met the main goal in a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Allergan's add-on treatment for depression fails late-stage studiesAllergan Plc said on Wednesday its experimental add-on treatment for major depressive disorder failed to meet the main goals of three late-stage ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »